Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes: Significance of Nicotine Flux to the Rate of Nicotine Delivery and Subjective Effect

NCT05430334 is registered in ClinicalTrials.gov with American University of Beirut Medical Center as lead sponsor.

NCT NCT05430334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05430334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotine Flux, a Potentially Powerful Tool for Regulating Nicotine Delivery From Electronic Cigarettes: Significance of Nicotine Flux to the Rate of Nicotine Delivery and Subjective Effect
Lead sponsor
American University of Beirut Medical Center
Phase
Not applicable
Overall status
Completed
Start date
July 13, 2022
Completion date
July 11, 2025
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine addiction, nicotine dependence, nicotine vaping